Brazilian Neurologists Tell CNN Brasil: Genetic Testing Advances Personalized Pediatric Epilepsy Treatment
Genetic testing is reshaping how pediatric epilepsy is diagnosed and treated, Brazilian neurologists told CNN Brasil on Saturday.
Key Clinical Takeaways:
- Molecular diagnostics now explain cases previously labeled idiopathic, directing clinicians away from harmful drugs.
- Specific gene variants — such as SCN1A and SLC2A1 — dictate precise therapeutic choices, including ketogenic diet or sodium-channel avoidance.
- Specialists describe a shift from empirical broad-spectrum prescribing to genotype-guided precision therapy.
Valente said molecular biology advances have turned formerly undiagnosable cases into genetically defined disorders. “Today those cases that before we had no diagnosis, now we have genetic diagnosis,” she told the program. Gene panels and exome sequencing, paired with specialized counseling, allow clinicians to pinpoint etiology and match therapy to mechanism.
“We are leaving the empirical and going to a personalized treatment.”
Valente said, contrasting the new model with the traditional classification of epilepsies as merely generalized or focal.
Genetic identification directly alters drug selection. Valente cited two examples: children with SLC2A1 variants impairing glucose transport across the blood-brain barrier — known as GLUT1 deficiency — respond to ketogenic diet rather than standard antiseizure medications.
In contrast, patients with SCN1A mutations, often presenting as Dravet syndrome with fever-sensitive prolonged seizures, must avoid sodium-channel blockers. “I will block even more this non-functioning channel,” Valente explained, warning that inappropriate use of those agents can worsen seizures and drive cognitive decline over a lifetime.
Epidemiology frames the clinical urgency. Epilepsy can arise at any age, but etiology shifts across the lifespan. In childhood, leading causes include perinatal injury, cortical malformations, infections, hemorrhage, and genetic factors persisting through adolescence. Adulthood brings traumatic brain injury from vehicle crashes and falls, stroke, and tumors. In older adults, vascular disease and neurodegenerative conditions such as Alzheimer’s disease predominate.
Access to comprehensive genetic evaluation remains uneven. Families facing a new diagnosis of refractory pediatric epilepsy should seek evaluation at a tertiary epilepsy center with dedicated neurogenetics expertise and metabolic dietitians for ketogenic therapy implementation.
Valente emphasized that the transition to genotype-directed care is underway but incomplete. “The medicine walks more and more toward a personalized model,” she said.
CNN Brasil, the Brazilian franchise of the global news network, launched on 15 March 2020 as a pay television channel and news website. It is owned by Novus Mídia, a joint venture between journalist Douglas Tavolaro and businessman Rubens Menin, operating under a licensing agreement with CNN Worldwide.
The channel is the second CNN affiliate in South America, following CNN Chile, and operates with almost 400 journalists from its headquarters in São Paulo and offices in Rio de Janeiro and Brasília.
Disclaimer: The information provided in this article is for educational and scientific communication purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider regarding any medical condition, diagnosis, or treatment plan.